MBOT
Microbot Medical Inc.
NASDAQ · Healthcare · Medical - Instruments & Supplies · US
$1.14
+4.59%Price chart
Oct 6Oct 9Oct 14Oct 19Oct 22Oct 27Oct 30Nov 4
Key dataNov 4, 2026
Open$1.14
From 52W high−60.00%
Volume768296.00
Market cap$76.57M
P/E (TTM)—
P/S (TTM)221.3x
Div yield—
Key dataNov 4, 2026
Open
$1.14
From 52W high
−60.00%
Volume
768296.00
Market cap
$76.57M
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−0.6x
P/E (TTM)
—
RSI (14)
53.1
MomentumView details →
1D Return
+4.59%
YTD Return
−43.75%
SummaryUpdated Jun 1, 2026
Microbot Medical Inc. (NASDAQ:MBOT) is a pre-clinical medical device company founded in 2010 and based in Hingham, Massachusetts. The company specializes in developing robotic endoluminal surgery devices for minimally invasive surgical procedures. Since going public in 1992, Microbot has focused on creating innovative micro-robotic technologies for various medical applications, including treatments for hydrocephalus and endovascular interventions. The company maintains a strategic collaboration with Stryker Corporation, a major medical technology company, for technology co-development purposes.
Similar companies
Latest newsMore news →
Microbot Medical Inc. secured ELMNT IR as the first office-based lab customer for its LIBERTY Endovascular Robotic System and its first West Coast account.9d agoMicrobot Medical and Medtechnica Ltd. entered into a three-year exclusive distribution agreement for the LIBERTY Endovascular Robotic System in Israel.30d ago